BrainsGate
2 known investors
BrainsGate develops a neurostimulation therapy for stroke patients based on stimulation of the sphenopalatine ganglion (SPG) to increase cerebral blood flow. The company operates in the medical device field, having conducted the ImpACT-24 clinical studies for acute ischemic stroke treatment.
BiotechHealthtechMedical Devices
Investors · 2
Frequently asked questions
- What does BrainsGate do?
- BrainsGate develops a neurostimulation therapy for stroke patients based on stimulation of the sphenopalatine ganglion (SPG) to increase cerebral blood flow. The company operates in the medical device field, having conducted the ImpACT-24 clinical studies for acute ischemic stroke treatment.
- Who are BrainsGate's investors?
- BrainsGate's investors include Agate Medical Investments LP, Cipio Partners.